-
Porton Biologics and Royaltech Med Partner on Bacterial and mRNA Drug Platforms
•
China-based contract development and manufacturing organization (CDMO) Suzhou Porton Biologics Ltd has partnered with Suzhou Royaltech Med Co., Ltd to establish bacterial (Listeria) and mRNA drug platform technologies. The collaboration aims to integrate both firms’ resources and capabilities, though financial terms were not disclosed. Company Profiles Strategic OutlookThe partnership will…
